Microboost in Localized Prostate Cancer: Analysis of a Statewide Quality Consortium.

ABSTRACT:

Purpose

Prospective trials have reported isotoxicity and improved oncologic outcomes with external beam radiation therapy (EBRT) microboost to a dominant intraprostatic lesion. There is often variability in the rate of adoption of new treatments, and current microboost practice patterns are unknown. We leveraged prospectively collected data from the multicenter Michigan Radiation Oncology Quality Consortium to understand the current state of microboost usage for localized prostate cancer.

Materials and methods

Men with intermediate- and high-risk prostate adenocarcinoma treated with curative-intent radiation between October, 26, 2020, and June, 26, 2023, were included across 26 centers. Demographic-, tumor-, and treatment-related data along with DICOM files were prospectivel

SUBMITTER: Regan SN 

PROVIDER: S-EPMC11602997 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature